Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody–Positive Neuromyelitis Optica Spectrum Disorder
Neurology Neuroimmunology & Neuroinflammation | July 13, 2026 | Volume: 13 | Issue: 5 | Pages: No page available
10.1212/nxi.0000000000200609
| PMID 42441931